Blood Cell Secretome Associated with Remote Ischemic Conditioning: Proteomic Profiling of Processes Linked to Neuroprotection in Experimental Stroke
Remote ischemic conditioning may improve the neuroprotective properties of blood cells, as evidenced by reduced infarct volume and oxidative stress in an experimental stroke model.
Where it sits
this study against the rest of the glutathione (gsh) corpusSummary and findings
This study examined the effects of remote ischemic conditioning (RIC) on blood cell secretome and its potential neuroprotective properties in an experimental stroke model. RIC-treated blood cells exhibited biochemical changes, including stable glutathione levels and increased catalase activity. The study reported a reduction in infarct volume and improved neurological scores following treatment.
Abstract
Ischemic stroke rapidly disrupts neuronal and synaptic integrity through excitotoxicity, oxidative stress, and inflammation, yet no effective neuroprotective therapy exists. Remote ischemic conditioning (RIC) is linked to systemic protective responses, but the molecular mechanisms by which circulating blood cells (BCs) contribute to RIC-mediated neuroprotection remain poorly understood. To address this gap, we examined whether RIC is associated with changes in BC properties and whether these changes correspond to alterations in the composition and function of their secretome. RIC-treated donor BCs exhibited biochemical features consistent with reduced hemo-lysis, maintained stable glutathione levels during incubation, and showed increased catalase activity, suggesting improved redox resilience. Secretomes from RIC-treated BCs showed elevated levels of the exosome-associated tetraspanin markers CD9 and CD81. Quantitative proteomics identified 680 proteins, of which 40 were differentially abundant (DAPs) between tolerant (TS) and non-tolerant secretomes (NTS). Most DAPs were downregulated in TS. GO enrichment analysis did not identify any significantly enriched terms after FDR correction. Because no GO term passed multiple testing cor-rection, GO results were not interpreted further. Functionally, TS treatment reduced infarct volume from 62.5% to 41.6%, improved neurological scores, and significantly decreased neuronal pyknosis, degeneration, and loss in the penumbra. TS also improved systemic redox balance, lowering oxidized glutathione, reducing the oxidative stress index from 3.5% to 1.9%, and diminishing the oxidative burden, as reflected in lymphocyte DNA damage, to near-control levels. Together, these findings indicate that TS derived from RIC treated donors exhibits neuroprotective potential in an experimental stroke model and is associated with dis-tinct proteomic signatures. The results are exploratory and do not establish a definitive mechanism or therapeutic readiness.
Background
This paper addresses the molecular mechanisms by which remote ischemic conditioning (RIC) may confer neuroprotection during ischemic stroke. Prior research has suggested that RIC can trigger systemic protective responses, but the specific contributions of circulating blood cells (BCs) to these effects remain unclear. Understanding these mechanisms is crucial for developing potential neuroprotective strategies.
Methods
The study utilized an experimental model of stroke to assess the effects of RIC on blood cell properties and their secretome. The population consisted of blood cells from RIC-treated donors, with a focus on biochemical features and proteomic profiling. Specific outcomes measured included infarct volume, neurological scores, and oxidative stress markers.
Results
The primary endpoint showed that TS treatment reduced infarct volume from 62.5% to 41.6%. Additionally, the oxidative stress index decreased from 3.5% to 1.9%. A total of 680 proteins were identified, with 40 being differentially abundant between tolerant and non-tolerant secretomes. No significantly enriched GO terms were reported after FDR correction.
Interpretation
These findings suggest that RIC may enhance the neuroprotective potential of blood cells through biochemical changes and alterations in their secretome. However, the effect sizes observed, while statistically significant, may not be clinically meaningful without further validation in human studies. The study's reliance on an experimental model and lack of human data limit the generalizability of the results.
Key findings
- Infarct volume reduced from 62.5% to 41.6% with TS treatment.
- Oxidative stress index decreased from 3.5% to 1.9%.
- 40 differentially abundant proteins identified between tolerant and non-tolerant secretomes.
- Lymphocyte DNA damage diminished to near-control levels.
- Increased catalase activity observed in RIC-treated blood cells.
Limitations
- Exploratory findings without definitive therapeutic claims.
- Lacks human trial data, relying on experimental models.
- No GO terms were significantly enriched after FDR correction.